For the quarter ending 2025-12-31, BNTC has $190,681K in assets. $3,320K in debts. $188,790K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 188,790 | 94,479 | 97,744 | |
| Restricted cash | 113 | 113 | 113 | |
| Trade and other receivables | 130 | 7 | 33 | |
| Prepaid and other assets | 562 | 480 | 628 | |
| Total current assets | 189,595 | 95,079 | 98,518 | |
| Total property and equipment, gross | 1,612 | 1,601 | 1,601 | |
| Accumulated depreciation and amortization | 1,497 | 1,483 | 1,470 | |
| Property and equipment, net | 115 | 118 | 131 | |
| Deposits | 55 | 55 | 55 | |
| Prepaid and other assets | 11 | 20 | 28 | |
| Right-of-use assets | 905 | 755 | 860 | |
| Total assets | 190,681 | 96,027 | 99,592 | |
| Trade and other payables | 1,850 | 1,148 | 1,022 | |
| Accrued employee benefits | 483 | 463 | 426 | |
| Lease liabilities, current portion | 468 | 414 | 354 | |
| Total current liabilities | 2,801 | 2,025 | 1,802 | |
| Non-current accrued employee benefits | - | - | 0 | |
| Lease liabilities, less current portion | 519 | 403 | 495 | |
| Total liabilities | 3,320 | 2,428 | 2,297 | |
| Common stock, 0.0001 par value -160,000,000 shares authorized 34,254,907 and 26,250,469 shares issued and outstanding at december 31, 2025 and june 30, 2025, respectively | 3 | 2 | 2 | |
| Additional paid-in capital | 437,219 | 331,488 | 326,308 | |
| Accumulated deficit | -248,978 | -237,141 | -228,176 | |
| Accumulated other comprehensive loss | -883 | -750 | -839 | |
| Total stockholders' equity | 187,361 | 93,599 | 97,295 | |
| Total liabilities and stockholders' equity | 190,681 | 96,027 | 99,592 | |
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC)